• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Antifungal susceptibility profiles for fungal isolates from corneas and contact lenses in the United Kingdom.英国角膜和隐形眼镜真菌分离株的抗真菌药敏谱。
Eye (Lond). 2024 Feb;38(3):529-536. doi: 10.1038/s41433-023-02719-1. Epub 2023 Sep 8.
2
Evaluation of antifungal susceptibility and clinical characteristics in fungal keratitis in a tertiary care center in North India.评估印度北部一家三级护理中心真菌性角膜炎的抗真菌药敏性和临床特征。
Indian J Ophthalmol. 2022 Dec;70(12):4270-4283. doi: 10.4103/ijo.IJO_855_22.
3
Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.从角膜炎中分离出的镰刀菌、曲霉菌及其他丝状真菌的药敏性
Arch Ophthalmol. 2007 Jun;125(6):789-93. doi: 10.1001/archopht.125.6.789.
4
In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial.来自角膜溃疡临床试验的丝状真菌分离株的体外药敏试验。
Am J Ophthalmol. 2014 Feb;157(2):318-26. doi: 10.1016/j.ajo.2013.10.004. Epub 2013 Oct 22.
5
Antifungal susceptibility and clinical efficacy of chlorhexidine combined with topical ophthalmic medications against species isolated from corneal samples.洗必泰联合局部眼科用药对从角膜样本中分离出的菌株的抗真菌药敏性及临床疗效
Front Cell Infect Microbiol. 2025 Apr 15;15:1532289. doi: 10.3389/fcimb.2025.1532289. eCollection 2025.
6
Activity of Chlorhexidine Compared with Seven Antifungal Agents against 98 Isolates Recovered from Fungal Keratitis Patients.氯己定对从真菌性角膜炎患者中分离出的 98 株分离株的活性与七种抗真菌药物的比较。
Antimicrob Agents Chemother. 2019 Jul 25;63(8). doi: 10.1128/AAC.02669-18. Print 2019 Aug.
7
Evaluation of topical 1% posaconazole therapy in refractory fungal keratitis.1%泊沙康唑局部治疗难治性真菌性角膜炎的评估
Indian J Ophthalmol. 2025 Jan 1;73(1):64-72. doi: 10.4103/IJO.IJO_1811_24. Epub 2024 Dec 23.
8
Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.泊沙康唑、雷夫康唑和伏立康唑与伊曲康唑及两性霉素B相比,对239株曲霉属及其他丝状真菌临床分离株的抗真菌活性:2000年SENTRY抗菌监测项目报告
Antimicrob Agents Chemother. 2002 Apr;46(4):1032-7. doi: 10.1128/AAC.46.4.1032-1037.2002.
9
Candida and candidaemia. Susceptibility and epidemiology.念珠菌与念珠菌血症。药敏性与流行病学。
Dan Med J. 2013 Nov;60(11):B4698.
10
In vitro susceptibility patterns of Aspergillus and Fusarium species isolated from equine ulcerative keratomycosis cases in the midwestern and southern United States with inclusion of the new antifungal agent voriconazole.美国中西部和南部马溃疡性角膜真菌病病例中分离出的曲霉菌和镰刀菌的体外药敏模式,包括新型抗真菌药伏立康唑。
Vet Ophthalmol. 2009 Sep-Oct;12(5):318-24. doi: 10.1111/j.1463-5224.2009.00721.x.

引用本文的文献

1
The IL-36γ/PEDF/PPARγ signalling pathway plays an anti-inflammatory role in Candida albicans keratitis.白细胞介素-36γ/色素上皮衍生因子/过氧化物酶体增殖物激活受体γ信号通路在白色念珠菌角膜炎中发挥抗炎作用。
Sci Rep. 2025 Aug 29;15(1):31926. doi: 10.1038/s41598-025-17965-4.
2
Antifungal susceptibility and clinical efficacy of chlorhexidine combined with topical ophthalmic medications against species isolated from corneal samples.洗必泰联合局部眼科用药对从角膜样本中分离出的菌株的抗真菌药敏性及临床疗效
Front Cell Infect Microbiol. 2025 Apr 15;15:1532289. doi: 10.3389/fcimb.2025.1532289. eCollection 2025.
3
Antifungal susceptibility, clinical findings, and biofilm resistance of Fusarium species causing keratitis: a challenge for disease control.引起角膜炎的镰刀菌属的抗真菌药敏性、临床特征及生物膜耐药性:疾病控制面临的一项挑战
Braz J Microbiol. 2025 Mar;56(1):341-352. doi: 10.1007/s42770-024-01611-8. Epub 2025 Jan 16.
4
Overview of Mycotic Keratitis.真菌性角膜炎概述。
Cornea. 2024 Sep 1;43(9):1065-1071. doi: 10.1097/ICO.0000000000003559. Epub 2024 May 8.

本文引用的文献

1
Assessing the efficacy of four methods established by four parameters in ICL size selection and relevant influencing factors: a prospective cohort study.评估四种基于四个参数建立的方法在ICL尺寸选择中的有效性及相关影响因素:一项前瞻性队列研究。
Int Ophthalmol. 2023 Dec;43(12):4861-4867. doi: 10.1007/s10792-023-02888-8. Epub 2023 Oct 14.
2
Diagnosis of Fungal Keratitis in Low-Income Countries: Evaluation of Smear Microscopy, Culture, and In Vivo Confocal Microscopy in Nepal.低收入国家真菌性角膜炎的诊断:尼泊尔涂片显微镜检查、培养及共聚焦显微镜活体检查评估
J Fungi (Basel). 2022 Sep 13;8(9):955. doi: 10.3390/jof8090955.
3
Keratitis in Taiwan: Molecular Identification, Antifungal Susceptibilities, and Clinical Features.台湾地区的角膜炎:分子鉴定、抗真菌药敏性及临床特征
J Fungi (Basel). 2022 May 3;8(5):476. doi: 10.3390/jof8050476.
4
Multicenter prospective observational study of fungal keratitis in Japan: analyses of in vitro susceptibility tests for combinations of drugs.日本真菌性角膜炎的多中心前瞻性观察研究:药物联合体外药敏试验分析
Jpn J Ophthalmol. 2022 May;66(3):240-253. doi: 10.1007/s10384-022-00907-2. Epub 2022 Mar 29.
5
Patterns of Antifungal Resistance in Adult Patients With Fungal Keratitis in South India: A Post Hoc Analysis of 3 Randomized Clinical Trials.印度南部成人真菌性角膜炎患者的抗真菌耐药模式:3 项随机临床试验的事后分析。
JAMA Ophthalmol. 2022 Feb 1;140(2):179-184. doi: 10.1001/jamaophthalmol.2021.5765.
6
Topical Chlorhexidine 0.2% versus Topical Natamycin 5% for the Treatment of Fungal Keratitis in Nepal: A Randomized Controlled Noninferiority Trial.尼泊尔局部应用 0.2%洗必泰与 5%那他霉素治疗真菌性角膜炎的随机对照非劣效性试验。
Ophthalmology. 2022 May;129(5):530-541. doi: 10.1016/j.ophtha.2021.12.004. Epub 2021 Dec 9.
7
Update on fungal keratitis in France: a case-control study.法国真菌性角膜炎最新情况:一项病例对照研究。
Acta Ophthalmol. 2022 Mar;100(2):159-163. doi: 10.1111/aos.14910. Epub 2021 May 24.
8
In Vitro Antifungal Drug Resistance Profiles of Clinically Relevant Members of the Mucorales (Mucoromycota) Especially with the Newer Triazoles.毛霉目(毛霉亚门)临床相关成员的体外抗真菌药物耐药谱,尤其针对新型三唑类药物。
J Fungi (Basel). 2021 Apr 2;7(4):271. doi: 10.3390/jof7040271.
9
Mycotic Keratitis-A Global Threat from the Filamentous Fungi.真菌性角膜炎——来自丝状真菌的全球威胁。
J Fungi (Basel). 2021 Apr 3;7(4):273. doi: 10.3390/jof7040273.
10
The global incidence and diagnosis of fungal keratitis.真菌性角膜炎的全球发病与诊断。
Lancet Infect Dis. 2021 Mar;21(3):e49-e57. doi: 10.1016/S1473-3099(20)30448-5. Epub 2020 Oct 22.

英国角膜和隐形眼镜真菌分离株的抗真菌药敏谱。

Antifungal susceptibility profiles for fungal isolates from corneas and contact lenses in the United Kingdom.

机构信息

Moorfields Eye Hospital, 162 City Road, London, EC1V 2PD, UK.

UCL Institute of Ophthalmology, 11-43 Bath Street, London, EC1V 9EL, UK.

出版信息

Eye (Lond). 2024 Feb;38(3):529-536. doi: 10.1038/s41433-023-02719-1. Epub 2023 Sep 8.

DOI:10.1038/s41433-023-02719-1
PMID:37684376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10858215/
Abstract

OBJECTIVE

To report the identification and results of susceptibility testing for fungal isolates from the cornea or contact lens care systems.

MATERIALS AND METHODS

In this retrospective epidemiological study, we searched the results of fungal cultures from cornea or contact lens systems referred for identification and susceptibility testing to the United Kingdom National Mycology Reference Laboratory between October 2016 and March 2022. For each fungal isolate, we recorded the genus and species of the fungus and the minimum inhibitory concentration (MIC) to six antifungal agents available to treat corneal infection (amphotericin, econazole, itraconazole, natamycin, posaconazole, and voriconazole).

RESULTS

There were 600 isolates from 585 patients, comprising 374 (62%) from corneal samples and 226 from contact lenses and care systems, of which 414 (69%) isolates were moulds (filamentous fungi) and 186 (31%) were yeasts. The most frequent moulds isolated were Fusarium spp (234 isolates, 39%) and Aspergillus spp (62, 10%). The most frequent yeasts isolated were Candida spp (112, 19%), predominantly Candida parapsilosis (65, 11%) and Candida albicans (33, 6%), with 35 isolates (6%) of Meyerozyma guilliermondii. In vitro susceptibility was greatest for natamycin (347 moulds tested, mode 4 mg/L, range 0.25-64 mg/L; 98 yeasts tested, mode 4 mg/L, range 0.5-32 mg/L), with susceptibility for 94% for moulds and 99% yeasts. Of the 16 isolates interpreted as highly resistant to natamycin (MIC ≥16 mg/L), 13 were Aspergillus flavus complex.

CONCLUSIONS

In vitro susceptibility supports the use of natamycin for the empiric treatment of fungal keratitis in the UK.

摘要

目的

报告从角膜或接触镜护理系统中分离的真菌进行鉴定和药敏试验的结果。

材料与方法

在这项回顾性流行病学研究中,我们检索了 2016 年 10 月至 2022 年 3 月间,送往英国国家真菌学参考实验室进行鉴定和药敏试验的角膜或接触镜系统真菌培养的结果。对于每一株真菌分离株,我们记录了真菌的属和种,以及治疗角膜感染的六种抗真菌药物(两性霉素、依康唑、伊曲康唑、那他霉素、泊沙康唑和伏立康唑)的最低抑菌浓度(MIC)。

结果

共有 585 例患者的 600 株分离株,其中 374 株(62%)来自角膜样本,226 株来自接触镜和护理系统,其中 414 株(69%)为霉菌(丝状真菌),186 株(31%)为酵母菌。分离出的最常见霉菌为镰孢菌属(234 株,39%)和曲霉属(62 株,10%)。分离出的最常见酵母菌为念珠菌属(112 株,19%),主要为近平滑念珠菌(65 株,11%)和白色念珠菌(33 株,6%),还有 35 株(6%)为季也蒙毕赤酵母。在体外,纳他霉素的敏感性最高(347 株霉菌检测,模式 4mg/L,范围 0.25-64mg/L;98 株酵母菌检测,模式 4mg/L,范围 0.5-32mg/L),霉菌的敏感性为 94%,酵母菌的敏感性为 99%。在 16 株被解释为对纳他霉素高度耐药(MIC≥16mg/L)的分离株中,有 13 株为黄曲霉复合体。

结论

体外药敏试验支持在英国使用纳他霉素治疗真菌性角膜炎。